NO965521L - N-substituert-(dihydroksyboryl)alkylpurin-, -indol- og -pyrimidinderivater som kan anvendes som inhibitorer for inflammatoriske cytokiner - Google Patents

N-substituert-(dihydroksyboryl)alkylpurin-, -indol- og -pyrimidinderivater som kan anvendes som inhibitorer for inflammatoriske cytokiner

Info

Publication number
NO965521L
NO965521L NO965521A NO965521A NO965521L NO 965521 L NO965521 L NO 965521L NO 965521 A NO965521 A NO 965521A NO 965521 A NO965521 A NO 965521A NO 965521 L NO965521 L NO 965521L
Authority
NO
Norway
Prior art keywords
indole
alkylpurine
inhibitors
substituted
inflammatory cytokines
Prior art date
Application number
NO965521A
Other languages
English (en)
Norwegian (no)
Other versions
NO965521D0 (no
Inventor
Bradley J Benson
Xiannong Chen
George J Cianciolo
Jose-Luis Lavandera Diaz
Khalid S Ishaq
Susan L Morris-Natschke
Ronald J Uhing
Henry Wong
Original Assignee
Macronex Inc
Univ North Carolina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Macronex Inc, Univ North Carolina filed Critical Macronex Inc
Publication of NO965521D0 publication Critical patent/NO965521D0/no
Publication of NO965521L publication Critical patent/NO965521L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Transplantation (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
NO965521A 1994-06-22 1996-12-20 N-substituert-(dihydroksyboryl)alkylpurin-, -indol- og -pyrimidinderivater som kan anvendes som inhibitorer for inflammatoriske cytokiner NO965521L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/264,039 US5643893A (en) 1994-06-22 1994-06-22 N-substituted-(Dihydroxyboryl)alkyl purine, indole and pyrimidine derivatives, useful as inhibitors of inflammatory cytokines
PCT/US1995/007936 WO1995035300A1 (en) 1994-06-22 1995-06-21 N-substituted-(dihydroxyboryl)alkyl purine, indole and pyrimidine derivatives, useful as inhibitors of inflammatory cytokines

Publications (2)

Publication Number Publication Date
NO965521D0 NO965521D0 (no) 1996-12-20
NO965521L true NO965521L (no) 1997-02-21

Family

ID=23004300

Family Applications (1)

Application Number Title Priority Date Filing Date
NO965521A NO965521L (no) 1994-06-22 1996-12-20 N-substituert-(dihydroksyboryl)alkylpurin-, -indol- og -pyrimidinderivater som kan anvendes som inhibitorer for inflammatoriske cytokiner

Country Status (16)

Country Link
US (1) US5643893A (es)
EP (1) EP0767793B1 (es)
JP (1) JP3805789B2 (es)
KR (1) KR970703975A (es)
AT (1) ATE224396T1 (es)
AU (1) AU2907795A (es)
CA (1) CA2193644A1 (es)
DE (1) DE69528267T2 (es)
DK (1) DK0767793T3 (es)
ES (1) ES2183877T3 (es)
FI (1) FI965141A0 (es)
HU (1) HUT76298A (es)
NO (1) NO965521L (es)
NZ (1) NZ289286A (es)
PT (1) PT767793E (es)
WO (1) WO1995035300A1 (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ502752A (en) * 1997-07-15 2001-01-26 Japan Energy Corp Purine derivatives and their use in the treatment of nephritis
US7462605B2 (en) * 1998-01-23 2008-12-09 Celmed Oncology (Usa), Inc. Phosphoramidate compounds and methods of use
US6911462B2 (en) * 1998-05-22 2005-06-28 Avanir Pharmaceuticals Benzimidazole compounds for regulating IgE
US6919366B2 (en) * 1998-05-22 2005-07-19 Avanir Pharmaceuticals Benzimidazole derivatives as modulators of IgE
BR0012676A (pt) 1999-07-22 2003-07-01 Newbiotics Inc Métodos para tratamento de tumores resistentes a terapia
US6586429B2 (en) * 2000-11-29 2003-07-01 Cell Therapeutics, Inc. Tricyclic fused xanthine compounds and their uses
US7138388B2 (en) * 2001-01-19 2006-11-21 Celmed Oncology (Usa), Inc. Methods to treat autoimmune and inflammatory conditions
CZ20032691A3 (en) * 2001-03-12 2004-04-14 Avanir Pharmaceuticals Benzimidazole compounds for modulating ige and inhibiting cellular proliferation
US20030022864A1 (en) * 2001-04-24 2003-01-30 Ishaq Khalid S. 9-[(5-dihydroxyboryl)-pentyl] purines, useful as an inhibitor of inflammatory cytokines
TW200304820A (en) * 2002-03-25 2003-10-16 Avanir Pharmaceuticals Use of benzimidazole analogs in the treatment of cell proliferation
TWI276631B (en) * 2002-09-12 2007-03-21 Avanir Pharmaceuticals Phenyl-aza-benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
WO2004024655A2 (en) * 2002-09-12 2004-03-25 Avanir Pharmaceuticals Phenyl-indole compounds for modulating ige and inhibiting cellular proliferation
CA2515530A1 (en) * 2003-02-11 2004-08-26 Boehringer Ingelheim International Gmbh New pharmaceutical compositions based on anticholinergics and inhibitors of tnf alpha synthesis or action
EP1651198A2 (en) * 2003-08-08 2006-05-03 Avanir Pharmaceuticals Selective pharmacologic inhibition of protein trafficking and related methods of treating human diseases
MY146066A (en) * 2004-07-01 2012-06-29 Microlin L C Device employing gas generating cell for facilitating controlled release of fluid into ambient environment
WO2007134169A2 (en) * 2006-05-10 2007-11-22 Nuada, Llc Indole, benzimidazole, and benzolactam boronic acid compounds, analogs thereof and methods of use thereof
US20090264384A1 (en) * 2004-11-01 2009-10-22 Nuada, Inc. Indole, benzimidazole, and benzolactam boronic acid compounds, analogs thereof and methods of use thereof
EP1812451A4 (en) * 2004-11-01 2009-10-21 Nuada Llc COMPOUNDS AND METHODS OF USE THEREOF
US20080269204A1 (en) * 2004-11-01 2008-10-30 Tatyana Dyakonov Compounds and Methods of Use Thereof
US20080319044A1 (en) * 2004-11-01 2008-12-25 Nuada, Llc Compounds and Methods of Use Thereof
JO3598B1 (ar) 2006-10-10 2020-07-05 Infinity Discovery Inc الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
AU2009234373B2 (en) * 2008-04-09 2015-09-24 Cornell University Coferons and methods of making and using them
CA2721060A1 (en) * 2008-04-09 2009-10-15 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
WO2010118155A1 (en) 2009-04-07 2010-10-14 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
WO2010118159A1 (en) 2009-04-07 2010-10-14 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
WO2010129351A1 (en) 2009-04-28 2010-11-11 Schepens Eye Research Institute Method to identify and treat age-related macular degeneration
CA2774476A1 (en) 2009-10-07 2011-04-14 Francis Barany Coferons and methods of making and using them
RU2015143910A (ru) 2010-02-03 2018-12-28 Инфинити Фармасьютикалз, Инк. Ингибиторы амид-гидролазы жирных кислот
EP2647639A1 (en) * 2012-04-06 2013-10-09 LEK Pharmaceuticals d.d. ß-boration of alkene and alkyne intermediates
EP3362462B1 (en) 2015-10-12 2021-07-21 Advanced Cell Diagnostics, Inc. In situ detection of nucleotide variants in high noise samples, and compositions and methods related thereto
IL319437A (en) 2022-09-07 2025-05-01 Mdx Man Llc Shp-1 inhibitors for treating cancer
WO2024097804A1 (en) 2022-11-02 2024-05-10 Mdx Management Llc Combination of a tyrosine kinase inhibitor and a pro-inflammatory agent for treating cancer
AU2024239074A1 (en) 2023-03-17 2025-10-02 Mdx Management Llc Compositions and methods for ameliorating adverse effects of therapies
WO2025038745A1 (en) 2023-08-16 2025-02-20 Mdx Management Llc Compositions and methods for activating immune cells
WO2025188920A1 (en) 2024-03-06 2025-09-12 Mdx Management Llc Local application of agents inhibiting tyrosine kinase or shp-1 signaling

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4199574A (en) * 1974-09-02 1980-04-22 Burroughs Wellcome Co. Methods and compositions for treating viral infections and guanine acyclic nucleosides
US4537773A (en) * 1983-12-05 1985-08-27 E. I. Du Pont De Nemours And Company α-Aminoboronic acid derivatives
GB8926611D0 (en) * 1989-11-24 1990-01-17 Xenova Ltd Compound and its use
US5130302A (en) * 1989-12-20 1992-07-14 Boron Bilogicals, Inc. Boronated nucleoside, nucleotide and oligonucleotide compounds, compositions and methods for using same
US5362732A (en) * 1989-12-20 1994-11-08 University Of North Carolina At Chapel Hill Boronated compounds
EP0584347B1 (en) * 1992-03-04 2003-01-15 Cell Therapeutics, Inc. Enantiomeric hydroxylated xanthine compounds
US5306722A (en) * 1992-09-02 1994-04-26 Bristol-Myers Squibb Company Thymidine derivatives and therapeutic method of use

Also Published As

Publication number Publication date
FI965141L (fi) 1996-12-20
US5643893A (en) 1997-07-01
PT767793E (pt) 2003-02-28
KR970703975A (ko) 1997-08-09
ES2183877T3 (es) 2003-04-01
JP3805789B2 (ja) 2006-08-09
DK0767793T3 (da) 2002-10-14
HUT76298A (en) 1997-07-28
EP0767793A1 (en) 1997-04-16
DE69528267D1 (de) 2002-10-24
NO965521D0 (no) 1996-12-20
EP0767793B1 (en) 2002-09-18
DE69528267T2 (de) 2003-04-17
HU9603536D0 (en) 1997-02-28
NZ289286A (en) 1998-09-24
CA2193644A1 (en) 1995-12-28
JPH10507739A (ja) 1998-07-28
AU2907795A (en) 1996-01-15
ATE224396T1 (de) 2002-10-15
FI965141A7 (fi) 1996-12-20
FI965141A0 (fi) 1996-12-20
WO1995035300A1 (en) 1995-12-28

Similar Documents

Publication Publication Date Title
NO965521L (no) N-substituert-(dihydroksyboryl)alkylpurin-, -indol- og -pyrimidinderivater som kan anvendes som inhibitorer for inflammatoriske cytokiner
NO965520D0 (no) Hydroksyalkylammoniumpyrimidiner eller -puriner, og nukleosidderivater, som kan anvendes som inhibitorer for inflammatoriske cytokiner
DE60314639D1 (de) Fusionierte heteroaryl-derivative zur verwendung als p38 kinase inhibitoren zur behandlung von u.a rheumatischer arthritis
FI950156A0 (fi) Dihydropyratsolopyrroleja
GB0209891D0 (en) Novel compounds
DK0594636T3 (da) 3-aminopiperidinderivater og relaterede nitrogenholdige heterocykliske forbindelser
YU48002A (sh) Derivati pirolidina kao inhibitori ciklične amp-specifične fosfodiesteraze
IL116122A0 (en) Intermediates to heterocyclic-cyclic amine derivatives
NO980313L (no) N-(aroyl)glysin-hydroksaminsyre-derivater og beslektete forbindelser
ZA200406813B (en) Glytaminyl based DPIV inhibitors
CA2299399A1 (en) Benzenesulfonamide inhibitors of pde-iv and their therapeutic use
NO900855L (no) Substituerte pyrroler.
DE60022637D1 (de) Pharmazeutische zusammensetzungen, enthaltend pyridin- oder pyrimidin-derivate, zur hemmung der produktion und sekretion von cytokinen
WO2002018320A3 (en) INHIBITORS OF α4 MEDIATED CELL ADHESION
NZ511885A (en) 2,3,4,5-tetrahydro-1H-[1,4]benzodiazephine-3-hydroxamic acid as matrix metalloproteinase inhibitors and as inhibitors of TNF-alpha converting enzyme (TACE)
AU6339200A (en) Urea derivatives as inhibitors of ccr-3 receptor
MXPA04004263A (es) Hidrazono-malonitrilos.
NZ336754A (en) Aminobenzophenones as inhibitors of interleukin and TNF
TW200420545A (en) 1-(4-benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives
AP2000001992A0 (en) Succinamide inhibitors of inteleukin-1B converting enzyme.
EA200100807A1 (ru) Производные алкинилсодержащих гидроксамовых кислот и их применение в качестве ингибиторов tace
DE60332931D1 (en) Hydroxamsäurederivate
MY127926A (en) Hydroxamic acid derivatives
MXPA04004010A (es) Acidos hidroxamicos de aril sulfonamida alenicos como inhibidores de tace y metaloproteinasa de matriz.
WO2005021489A3 (en) Acetylenic aryl sulfonate hydroxamic acid tace and matrix metalloproteinase inhibitors